US Stock MarketDetailed Quotes

RDHL Redhill Biopharma

Watchlist
  • 6.500
  • +0.030+0.46%
Close Dec 20 16:00 ET
  • 6.690
  • +0.190+2.92%
Post 20:01 ET
8.29MMarket Cap-0.02P/E (TTM)

About Redhill Biopharma Company

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolRDHL
Company NameRedhill Biopharma
Listing DateDec 27, 2012
Founded2009
CEOMr. Dror Ben-Asher
MarketNASDAQ
Employees61
Securities TypeDR
ADS Ratio1.0 : 400.0
Fiscal Year Ends12-31
Address21 Ha'arba'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6473921
Phone972-3-541-3131
Websitehttp://www.redhillbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dror Ben-Asher
  • Chairman of the Board and Chief Executive Officer
  • 594.61K
  • Razi Ingber
  • Chief Financial Officer
  • 354.22K
  • Rick D. Scruggs
  • Director and Chief Commercial Officer
  • 469.80K
  • Gilead Raday
  • Chief Operating Officer
  • 379.96K
  • Adi Frish
  • Chief Corporate and Business Development Officer
  • 353.70K
  • Guy Goldberg
  • Chief Business Officer
  • --
  • Dr. Reza Fathi
  • Senior Vice President, Research and Development
  • --
  • Dr. Shmuel Cabilly
  • Independent Director
  • --
  • Eric Swenden
  • Independent Director
  • --
  • Ofer Tsimchi
  • Independent Director
  • --
  • Alla Felder
  • Independent Director
  • --
  • Dr. Kenneth Reed
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data